SCHEMBL2592829

SCHEMBL2592829

CCOc1ccn(CC)c(=O)c1C(=O)Oc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
THRB P10828 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 5/20 0.36
FAAH O00519 1/20 0.36
MAOB P27338 1/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
KDM4E B2RXH2 1/20 0.35
AXL P30530 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1548165 0.84 FAAH (0.42) CYP1A2CYP2D6CYP2C19L3MBTL1ALDH1A1
SCHEMBL28554633 0.77 L3MBTL1 (0.39) L3MBTL1ALDH1A1MAPTLMNAKMT2A
SCHEMBL23749288 0.74 MAPK14 (0.48) L3MBTL1THRBALDH1A1MAPTFAAH
SCHEMBL15506048 0.74 MAPK14 (0.48) L3MBTL1THRBALDH1A1MAPTFAAH
SCHEMBL3665276 0.72 AXL (0.49) ALDH1A1LMNAKMT2AMEN1NPC1
SCHEMBL14705756 0.68 MET (0.50) L3MBTL1ALDH1A1MAPTNPC1RAB9A
SCHEMBL721541 0.68 MET (0.50) ALDH1A1MAPTLMNANPC1RAB9A
SCHEMBL1548236 0.68 LMNA (0.49) THRBALDH1A1MAPTLMNARAB9A
SCHEMBL23071634 0.68 MET (0.52) ALDH1A1MAPTKMT2AMEN1NPC1
SCHEMBL2592272 0.68 MET (0.51) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782577-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES Deciphera Pharmaceuticals, LLC. (US) 2014-10-01 EP disclosed
WO-2014145004-A1 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES DECIPHERA PHARMACEUTICALS, LLC (US) 2014-09-18 WO disclosed
WO-2013078295-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES DECIPHERA PHARMACEUTICALS, LLC (US) 2013-05-30 WO disclosed
EP-2563773-A1 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITES Deciphera Pharmaceuticals, LLC (US) 2013-03-06 EP disclosed
WO-2011139891-A1 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITES DECIPHERA PHARMACEUTICALS, LLC (US) 2011-11-10 WO disclosed
EP-2235001-A1 4-PYRIDINONE COMPOUNDS AND THEIR USE FOR CANCER Bristol-Myers Squibb Company (US) 2010-10-06 EP disclosed
WO-2009094427-A1 4-PYRIDINONE COMPOUNDS AND THEIR USE FOR CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2009-07-30 WO disclosed